Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 4 | Unknown | PO / MO |
The patient took four doses of Vivotif every day instead every other day; Case reference number US-BN-2024-002323 is a spontaneous case initially received from physician via agency (reference number USBAV24-1918) on 08-Aug-2024 and concerns a female patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On 05-Aug-2024, the patient took the first dose of Vivotif (batch number: unknown), at unknown dose, orally, for unknown indication. On 06-Aug-2024, one day after the first dose of Vivotif, the patient took the second dose of Vivotif (batch number: unknown), at unknown dose, orally (explicitly coded as 'Inappropriate schedule of vaccine administered') On 07-Aug-2024, one day after the second dose of Vivotif, the patient took the third dose of Vivotif (batch number: unknown), at unknown dose, orally (explicitly coded as 'Inappropriate schedule of vaccine administered') On 08-Aug-2024, one day after the third dose of Vivotif, the patient took the fourth dose of Vivotif (batch number: unknown), at unknown dose, orally (explicitly coded as 'Inappropriate schedule of vaccine administered') At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. Non-significant follow-up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240808-07c058 to US-BAVARIAN NORDIC A/S-US-BN-2024-002323, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A female patient received four doses of Vivotif, given every day one after another, instead of every other day. This is considered inappropriate schedule of vaccine administered. No associated adverse events were reported. Inappropriate schedule of vaccine administered is considered listed per company convention. Medical history and concomitant medications were not reported. Inappropriate schedule of vaccine administered is not related to Vivotif, but to human factors. The case is non-serious.; Sender's Comments: A female patient received four doses of Vivotif, given every day one after another, instead of every other day. This is considered inappropriate schedule of vaccine administered. No associated adverse events were reported. Inappropriate schedule of vaccine administered is considered listed per company convention. Medical history and concomitant medications were not reported. Inappropriate schedule of vaccine administered is not related to Vivotif, but to human factors. The case is non-serious.
Comments: None